2019
Jon Johnsson appointed new CFO of Karo Pharma
Karo Pharma Aktiebolag (publ) (“Karo Pharma”) has appointed Jon Johnsson as the new CFO of Karo Pharma, replacing Mats-Olof Wallin,…
Clarification of the statement in the interim report published 19 July 2019 regarding the rights issue with pre-emptive rights
Karo Pharma Aktiebolag (”Karo Pharma”) today published its interim report for the period January – June 2019. On page 2…
INTERIM REPORT JANUARY – JUNE 2019
THE PERIOD AND THE SECOND QUARTER
Karo Pharma acquires Trimb for MSEK 3,400 and intends to carry out a rights issue of approximately MSEK 1,500
Karo Pharma AB (publ) (the ”Company” or ”Karo Pharma”) has today acquired all the shares of Trimb Holding AB (“Trimb”)…
ANNUAL GENERAL MEETING 2019 IN KARO PHARMA AKTIEBOLAG
At today’s annual general meeting of Karo Pharma, the following decisions were passed. The annual general meeting resolved to adopt…
INTERIM REPORT THE FIRST QUARTER 2019
· Net sales amounted to MSEK 420.8 (267.1). This corresponds to an increase of 58%. The growth is attributable to…
NOTICE OF ANNUAL GENERAL MEETING IN KARO PHARMA AKTIEBOLAG
The shareholders of Karo Pharma Aktiebolag, reg. no. 556309-3359, are given notice of the annual general meeting to be held…
Karo Pharma publishes the 2018 annual report
Karo Pharma publishes its annual report for 2018. Today, on 9 April 2019, Karo Pharma is publishing its annual report…
New date for the annual general meeting of Karo Pharma
STOCKHOLM on 9 April 2019